Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7420 p384
30 September 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Fears clinical engagement will be lost as new PCTs kick off

New primary care trusts in England come into being next week and many are still to appoint chairmen and chief executives, which could take the PCTs' focus away from clinical engagement.

The NHS Appointments Commission confirmed this week that only 99 of the 152 PCT chairmen have been appointed. However, it added that more appointments are to be considered this weekend. Non-executive directors will not be appointed until a chairman is in position.

Brian Jolley, a pharmacist and currently chairman of the professional executive committee at Waveney PCT, warns that there is a danger that PCTs which have not appointed chairmen and chief executives will lose clinical engagement.

At the same time, the membership and functions of professional executive committees (PECs) are under review by the Government (PJ, 16 September, p325) meaning that all new PECs in reconfigured PCTs are an interim measure. “I have heard of some PECs being formed which are smaller and more focussed. In the confusion, clinical engagement may be lost, with PCTs falling back on practice-based commissioning for clinical involvement. This could prove to be a threat for pharmacy and other professions,” said Mr Jolley. In non-reconfigured PCTs the existing PECs will be retained until the review is completed.

Back to Top


©The Pharmaceutical Journal